Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Human/Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-STRADA (25-210) is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:1000-1:2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
STRADA |
Gene ID: |
92335 |
Uniprot ID: |
STRAA_HUMAN |
Immunogen Region: |
25-210 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 25-210 of human STRADA (NP_699166.2). |
Immunogen Sequence: |
FLPEGGCYELLTVIGKGFED LMTVNLARYKPTGEYVTVRR INLEACSNEMVTFLQGELHV SKLFNHPNIVPYRATFIADN ELWVVTSFMAYGSAKDLICT HFMDGMNELAIAYILQGVLK ALDYIHHMGYVHRSVKASHI LISVDGKVYLSGLRSNLSMI SHGQRQRVVHDFPKYSVKVL PWLSPE |
Function | Pseudokinase which, in complex with CAB39/MO25 (CAB39/MO25alpha or CAB39L/MO25beta), binds to and activates STK11/LKB1. Adopts a closed conformation typical of active protein kinases and binds STK11/LKB1 as a pseudosubstrate, promoting conformational change of STK11/LKB1 in an active conformation. |
Protein Name | Ste20-Related Kinase Adapter Protein AlphaStrad AlphaSte20-Related Adapter ProteinSerologically Defined Breast Cancer Antigen Ny-Br-96 |
Database Links | Reactome: R-HSA-380972 |
Cellular Localisation | NucleusCytoplasm |
Alternative Antibody Names | Anti-Ste20-Related Kinase Adapter Protein Alpha antibodyAnti-Strad Alpha antibodyAnti-Ste20-Related Adapter Protein antibodyAnti-Serologically Defined Breast Cancer Antigen Ny-Br-96 antibodyAnti-STRADA antibodyAnti-LYK5 antibodyAnti-STRAD antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance